- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Contrast MRA reduces cost for PVD diagnosis
The Veterans Affairs system could have saved more than $13 million in six years by using contrast-enhanced MR angiography instead of digital subtraction angiography for peripheral vascular disease imaging, according to a multicenter study presented at the 2006 International Society of Pharmacoeconomics and Outcomes Research meeting.
The Veterans Affairs system could have saved more than $13 million in six years by using contrast-enhanced MR angiography instead of digital subtraction angiography for peripheral vascular disease imaging, according to a multicenter study presented at the 2006 International Society of Pharmacoeconomics and Outcomes Research meeting.
J.W. Hay, Ph.D., an associate professor of pharmaceutical economics and policy at the University of Southern California, retrospectively reviewed VA outpatient data on almost 20,000 patients who underwent DSA and CE-MRA from 1999 to 2004. He found that use of CE-MRA reduced imaging costs by 55% over DSA. Costs per procedure were reduced by $950 compared with DSA.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
